KROTH HEIKO,HAMEL COTINICA,BENDERITTER PASCAL,FROESTL WOLFGANG,SREENIVASACHARY NAMPALLY,MUHS ANDREAS
申请号：
NZ60277711
公开号：
NZ602777A
申请日:
2011.04.15
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
The present disclosure relates to compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer&rsquos disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present disclosure can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present disclosure further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed.
